The market's minnows are swimming away from its whales as the Russell 2000 Index is up about 8% compared with the 5% gain in the S&P 500. Ralph Bassett, portfolio manager for the Aberdeen US Small Cap Equity Fund GSXAX, says there are a slew of good reasons for the surge in small caps. "They get more domestic orientation so they have less volatility and overseas revenue. Meanwhile, M&A activity in the sector is holding strong," says Bassett. Bassett is particularly bullish on Parexel International (PRXL) . Shares of the biopharmaceutical services company, which provides clinical research and logistics, are flat year-to-date. He is also positive on shares of G-III Apparel Group (GIII) , down 37% year-to-date, saying the company's management is strong enough to get through its short term issues surrounding its Donna Karan acquisition. Finally, Bassett is a fan of Quaker Chemical (KWR) , up 35% thus far in 2016, saying the company's "robust business model" gives it room for margin expansion.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.